SLRN Archived Articles
Acelyrin, Inc. (SLRN): A Biopharma Innovator Reshaping the Immune-Mediated Disease Landscape
Published on March 16, 2025
ACELYRIN, INC. (NASDAQ:SLRN) - A Late-Stage Biopharma Focused on Transformative Medicines
Published on September 24, 2024